Ocular allergy ranges from seasonal and perennial allergic conjunctivitis to chronic, potentially sight-threatening vernal keratoconjunctivitis (VKC). African prevalence studies use heterogeneous terminology and case-ascertainment methods, and their estimates have not previously been synthesized. To synthesise published prevalence estimates of ocular allergy among African children, quantify uncertainty around summary estimates, and describe between-study variation. PubMed/MEDLINE, Google Scholar, African Journals Online and African Index Medicus were searched for observational studies published from 1 January 2010 to 31 December 2025. Disease-specific terms were supplemented with broader ocular-morbidity terminology, reference-list screening and citation verification to identify studies reporting ocular allergy as a secondary outcome. Eligible studies enrolled African children and provided an extractable numerator and denominator. Logit-transformed proportions were pooled using a random-effects restricted maximum-likelihood (REML) model in Stata 17. Heterogeneity, 95% prediction intervals, diagnostic and setting subgroups, and sensitivity analyses were reported. Fourteen studies from five countries included 18,681 children, of whom 1,911 had ocular allergy, allergic conjunctivitis or VKC/vernal disease. The pooled prevalence was 9.4% (95% confidence interval [CI] 5.4%–15.6%), with extreme heterogeneity (τ2 = 1.23; I2 = 99.19%; Q(13) = 1844.38, p < 0.001) and a 95% prediction interval of 0.8%–55.9%. The pooled estimate was 14.5% (95% CI 5.5%–33.0%; k = 6) for allergic conjunctivitis and 6.6% (95% CI 3.8%–11.2%; k = 8) for VKC/vernal disease; the subgroup difference was not statistically significant (Q β (1) = 1.99, p = 0.158). School/community studies yielded 8.9% (95% CI 5.0%–15.4%; k = 13), whereas the single clinic study reported 17.6% (95% CI 15.8%–19.6%). Substituting a narrower VKC case definition gave 8.4% (95% CI 4.9%–14.2%), and leave-one-out estimates ranged from 8.0% to 10.2%. Published studies consistently report ocular allergy among African children, although the available evidence is too heterogeneous to support a reliable continental prevalence estimate. Variation in case definition and ascertainment is a plausible and likely substantial contributor, but could not be quantified formally. The findings support consideration of ocular allergy within school eye-health and primary eye-care programmes while underscoring the need for standardised diagnostic and reporting methods.
No takes yet. Share an insight, caveat, or question.
Ismail et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: